Tom Cech's lab is focused, in part, on studying telomerase: a powerful enzyme found at the ends of chromosomes.

Live Cells reveal cancer process

Aug. 11, 2016

A deep look inside the live cells reveals a key cancer process Telomerase, a powerful enzyme found at the ends of chromosomes, can keep humans healthy, or promote cancer growth. Researchers at the University of Colorado in Boulder used a process called single-molecule imaging to look into the complicated processes...

Phil Richardson, an author on a paper recently published in Nature, developed a love for bioinformatics in BioFrontiers' Robin Dowell's lab. His next move: pursuing a graduate degree in medical genomics.

Bioinformatics answers questions

June 5, 2015

Bioinformatics answers questions of cancer and career path Phil Richardson, an author on a paper recently published in Nature, developed a love for bioinformatics in BioFrontiers' Robin Dowell's lab. His next move: pursuing a graduate degree in medical genomics. At some point in school, we were taught that humans are...

BioFrontiers Hubert Yin is focused on toll-like receptors that may play a role in new cancer therapies.

Unlocking toll-like receptors

April 10, 2015

BioFrontiers’ Hubert Yin is unlocking the power of toll-like receptors Hubert Yin has been thinking about one type of cell receptor since he joined the BioFrontiers Institute, and it is a receptor worthy of that kind of time. Yin, an Associate Professor of Chemistry and Biochemistry, is focusing much of...

Telomeres sit at the ends of chromosomes to protect their genetic data (colorful DNA pic) Credit: Jane Ades, NHGRI

Research on small cellular changes may lead to big cancer solutions

March 10, 2015

Among cancers, scientists have spent their entire research careers looking for cellular similarities that may lead to a single cure for many cancers –– the rare chance to have a single answer to a multifaceted problem. In 1997, scientists discovered a gene that they believed was the key to cellular...

Robin Dowell collaborated with MCDB's Joaquin Espinosa and Mary Allen (pictured below) to make sense of p53.

New Technology, New Understanding of p53: The Tumor-Suppressor Gene

May 14, 2014

A major collaboration of Colorado institutions uses new technology to show, after more than 30 years and 50,000 papers on the subject, the direct targets of the gene p53, the most potent “tumor suppressor” gene. The finding is a strong step toward affecting the disease trajectories of nearly all cancer...

Telomeres sit at the ends of chromosomes to protect their genetic data. Credit: Jane Ades, NHGRI

BioFrontiers researchers uncover new target for cancer research

Oct. 24, 2012

In a new paper released today in Nature , BioFrontiers Institute scientists at the University of Colorado in Boulder, Tom Cech and Leslie Leinwand, detailed a new target for anti-cancer drug development that is sitting at the ends of our DNA. Researchers in the two scientists’ laboratories collaborated to find...

Biofrontiers scientist, Hubert Yin, is focused on making morphine more effective and less addictive.

Biofrontiers researcher rethinks morphine's effects

May 7, 2012

A University of Colorado Boulder-led research team has discovered that two protein receptors in the central nervous system team up to respond to morphine and cause unwanted neuroinflammation, a finding with implications for improving the efficacy of the widely used painkiller while decreasing its abuse potential. Scientists have known that...

Sara

Undergrad selected for cancer award

March 8, 2012

Yin Lab Student Selected for Cancer Award Sara Coulup, a junior undergraduate majoring in biochemistry, has been selected by the American Association of Cancer Research (AACR) for a 2012-2013 Thomas J. Bardos Science Education Award for Undergraduate Students. This two-year award is intended to inspire young science students to enter...

Biofrontiers Institute scientist, Hang (Hubert) Yin’s, focus on the Epstein Barr virus is leading him to a greater understanding of how cancer invades cells. Photo courtesy: Glenn Asakawa, University of Colorado Boulder

Stopping cancer's knock on the door

Dec. 6, 2011

Stopping cancer's knock on the door As a self-proclaimed “science nerd” in a Beijing high school, Hubert Yin considered biochemistry to be the ultimate in cool. It was the only science, he felt, that was capable of explaining what he thought was the most complex, most beautiful thing on earth–...

Biofrontiers scientist, Hubert Yin, is using fluorescent biomarkers to develop a better screening method for cancer.

Biomarkers light the way to cancer diagnosis

Sept. 13, 2011

Biomarkers light the way to cancer diagnosis In an 18-year study released this summer by the National Cancer Institute, widespread screening for ovarian cancer was found to be ineffective in catching the disease. In fact, the screening often did more harm than good, leading women to unnecessary surgery and the...

Pages